Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

BACKGROUND: The main advantage of GeneXpert MTB/RIF® (Xpert) molecular diagnostic technology is the rapid detection of M.tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmission of the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Infect Dis
Hlavní autoři: Ershova, Julia V., Volchenkov, Grigory V., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Kaminski, Dorothy, Demikhova, Olga V., Chernousova, Larisa N., Vasilyeva, Irina A., Kerr, Eleanor M., Cegielski, J. Peter, Kurbatova, Ekaterina V.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7382080/
https://ncbi.nlm.nih.gov/pubmed/32711457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05243-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky